SCHEDULE 13-D

Company

AMICUS THERAPEUTICS, INC.

Filed

August 7, 2007

Accession Number

0001072613-07-001778

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →